EEF2K and gastric adenocarcinoma: eEF2K is a useful therapeutic target as it has been identified as an indicator of stomach adenocarcinoma and decreased expression of eEF2K in esophageal squamous cell carcinoma facilitated greater apoptosis [197, 198].